JW Therapeutics Announces NMPA Acceptance of the Supplemental New Drug Application for Carteyva® in Patients with Relapsed or Refractory Follicular Lymphoma

SHANGHAI, Feb. 27, 2022 /PRNewswire/ — JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focused on developing,…

Pakistan’s ‘Truck It In’ Startup Raises the Largest Seed Round in MENAP Trucking Space

The seed round was co-led by Global Founders Capital and Fatima Gobi Ventures.  Other participating investors…

MILG to Build New HQ Building for Bangsamoro PNP

Php40 million for new BARMM PRO BAR HQ, Php25 million for new Wao Public Market BARMM…

‘Breaking Off Ties Strongly Discouraged in Islam’

“Whoever believes in Allah and the Last Day, let him maintain the bonds of kinship.” —…